Reshaping the Future Together
AIM at Melanoma (aimatmelanoma.org) scores 81 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, Non-profit brands, in the 77th percentile of 13754 Healthcare brands.
AIM at Melanoma is a global nonprofit foundation, founded in 2004 and headquartered in Richmond, United States, dedicated to finding more effective treatments and ultimately a cure for melanoma. It funds research, provides patient and caregiver support, and engages in advocacy efforts. Its work targets melanoma patients, survivors, families, caregivers, donors, researchers, and healthcare providers, positioning itself as a bridge between scientific advancement and practical patient support on a global scale.
| Brand Name | AIM at Melanoma |
|---|---|
| Domain | aimatmelanoma.org |
| Industry | Healthcare, Non-profit |
| Founded | 2004 |
| Headquarters | Richmond, United States |
| Main Competitors | Melanoma Research Alliance (78/100), Melanoma Research Foundation (82/100), Skin Cancer Foundation, American Cancer Society (94/100), American Melanoma Foundation |
Moz Domain Authority 55/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #374,530 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Founded in 2004, AIM at Melanoma is a global foundation dedicated to finding more effective treatments and, ultimately, the cure for melanoma." (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:type, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram, YouTube; no detected presence on LinkedIn, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is AIM at Melanoma?", Claude could identify the brand as of October 2026. AIM at Melanoma is a nonprofit organization dedicated to funding melanoma research and supporting patients and families affected by melanoma through education, advocacy, and connection to resources. Best known for Funding melanoma research and providing patient support and advocacy for melanoma patients and their families.
When asked "Best brands similar to AIM at Melanoma?", Claude would recommend AIM at Melanoma as of October 2026. It's a well-known and respected nonprofit in the melanoma research and patient advocacy space, so I'd mention it alongside other melanoma-focused charities.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
AIM at Melanoma's main competitors in Healthcare: Melanoma Research Alliance (78/100), Melanoma Research Foundation (82/100), American Cancer Society (94/100).
Sources: Brand Analyzer scan
AIM at Melanoma is a global nonprofit foundation, founded in 2004 and based in Richmond, United States, dedicated to funding research and supporting patients in the fight against melanoma. It operates within the healthcare and non-profit sectors, working toward more effective treatments and ultimately a cure for the disease.
Sources: AIM at Melanoma official site
AIM at Melanoma has limited AI-search visibility, scoring 37/100 on Brand Analyzer's AI visibility composite (visibility 26, trust 30, recommendation 66). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: AIM at Melanoma official site
AIM at Melanoma was founded in 2004. AIM at Melanoma operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
AIM at Melanoma funds global melanoma research aimed at developing more effective treatments and a cure. It also provides support and practical resources to melanoma patients, survivors, and their families, and engages in advocacy to advance melanoma treatment and awareness among researchers and healthcare providers.
Sources: AIM at Melanoma official site
AIM at Melanoma scores 66/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: AIM at Melanoma official site
AIM at Melanoma offers research funding for melanoma studies, patient and caregiver support resources, and advocacy initiatives aimed at advancing melanoma treatment and working toward a cure. It serves as a resource hub connecting patients, families, donors, researchers, and healthcare providers.
Sources: AIM at Melanoma official site
AIM at Melanoma can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: AIM at Melanoma official site
AIM at Melanoma serves melanoma patients, survivors, and their families and caregivers who seek support and information, as well as donors who fund its mission, researchers studying melanoma treatments, and healthcare providers involved in melanoma care.
Sources: AIM at Melanoma official site
AIM at Melanoma is known for its role as a global foundation combining research funding with direct patient support, positioning itself as a bridge between scientific advancement and practical help for those affected by melanoma.
Sources: AIM at Melanoma official site
AIM at Melanoma scores 37/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
AIM at Melanoma has a weak AI-visibility profile at 37/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (66/100) and its weakest is visibility (26/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #374,530 (Tranco) and a Moz Domain Authority of 55/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify AIM at Melanoma from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to AIM at Melanoma: AIHA (81/100), Association for Healthcare Philanthropy (81/100), Carelon (81/100), Aires Tech (81/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.